Evidence map›Paper›PMID 32730915›Full record

ReviewProgress in neuro-psychopharmacology & biological psychiatry2021

The SARS-CoV-2 and mental health: From biological mechanisms to social consequences.

Dorota Szcześniak, Anna Gładka, Błażej Misiak, Agnieszka Cyran, Joanna Rymaszewska

Open access · greenAbstract readReview
In one paragraph

Review in Progress in neuro-psychopharmacology & biological psychiatry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 59 papers.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed
11.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 149 citations in OpenAlex.

  1. Observational
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Psycho-Cardiological Disease in COVID-19 Era.Reviews in cardiovascular medicine · 2023
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Impact of COVID-19 on Health-Related Quality of Life: A Longitudinal Study in a Spanish Clinical Sample.International journal of environmental research and public health · 2022
    Observational
  17. Article
  18. Reviving the mutual impact of SARS-COV-2 and obesity on patients: From morbidity to mortality.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2022
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Dorota SzcześniakDepartment of Psychiatry, Wroclaw Medical University, Wybrzeże Ludwika Pasteura 10, 50-367 Wrocław, Poland.
Anna GładkaDepartment of Psychiatry, Wroclaw Medical University, Wybrzeże Ludwika Pasteura 10, 50-367 Wrocław, Poland. Electronic address: anna.gladka@student.umed.wroc.pl.
Błażej MisiakDepartment of Psychiatry, Wroclaw Medical University, Wybrzeże Ludwika Pasteura 10, 50-367 Wrocław, Poland. Electronic address: blazej.misiak@umed.wroc.pl.
Agnieszka CyranDepartment of Psychiatry, Wroclaw Medical University, Wybrzeże Ludwika Pasteura 10, 50-367 Wrocław, Poland. Electronic address: agnieszka.cyran@umed.wroc.pl.
Joanna RymaszewskaDepartment of Psychiatry, Wroclaw Medical University, Wybrzeże Ludwika Pasteura 10, 50-367 Wrocław, Poland. Electronic address: joanna.rymaszewska@umed.wroc.pl.
Wroclaw Medical University · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In December 2019, the first case of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID-19) infection was reported. In only few weeks it has caused a global pandemic, with mortality reaching 3.4%, mostly due to a severe pneumonia. However, the impact of SARS-CoV-2 virus on the central nervous system (CNS) and mental health outcomes remains unclear. Previous studies have demonstrated the presence of other types of coronaviruses in the brain, especially in the brainstem. There is evidence that the novel coronavirus can penetrate CNS through the olfactory or circulatory route as well as it can have an indirect impact on the brain by causing cytokine storm. There are also first reports of neurological signs in patients infected by the SARS-Cov-2. They show that COVID-19 patients have neurologic manifestations like acute cerebrovascular disease, conscious disturbance, taste and olfactory disturbances. In addition, there are studies showing that certain psychopathological symptoms might appear in infected patients, including those related to mood and psychotic disorders as well as post-traumatic stress disorder. Accumulating evidence also indicates that the pandemic might have a great impact on mental health from the global perspective, with medical workers being particularly vulnerable. In this article, we provide a review of studies investigating the impact of the SARS-CoV-2 on the CNS and mental health outcomes. We describe neurobiology of the virus, highlighting the relevance to mental disorders. Furthermore, this article summarizes the impact of the SARS-CoV-2 from the public health perspective. Finally, we present a critical appraisal of evidence and indicate future directions for studies in this field.

Indexed as

Mental HealthBetacoronavirusBrainCoronavirus InfectionsCOVID-19HumansMental DisordersNervous System DiseasesPandemicsPneumonia, ViralSARS-CoV-2Treatment Outcome

Identifiers

PMID32730915
PMCPMC7384993
OpenAlexW3044143894

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.